Abstract
With the growing complexity of vascular interventional radiology, a larger array of drug treatments is employed by practitioners undertaking these procedures. Furthermore, patients attending for treatment are likely to be on combinations of drugs which may interact with medications employed during endovascular procedures. This chapter describes the mechanisms of action of drugs commonly used in this patient group and illustrates the likely interactions that may be encountered during endovascular procedures.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Cattaneo M, Podda GM (2010) State of the art of new \(\hbox{P}_{{2Y}_{12}}\) antagonists. Intern Emerg Med 5:385–391
Chang WS, Wardell MR, Lomas DA, Carrell RW (1996) Probing serpin reactive-loop conformations by proteolytic cleavage. Biochem J 314:647–653
Coggins MP, Bloch KD (2007) Nitric oxide in the pulmonary vasculature. Arterioscler Thromb Vasc Biol 27:1877–1885
Dirkmann D, Görlinger K, Gisbertz C, Dusse F, Peters J (2012) Factor XIII and tranexamic acid but not recombinant factor VIIa attenuate tissue plasminogen activator-induced hyperfibrinolysis in human whole blood. Anesth Analg. doi:10.1213/ANE.0b013e31823b6683 (Epub ahead of print)
Duncker DJ, Bache RJ (2008) Regulation of coronary blood flow during exercise. Physiol Rev 88:1009–1086
Eriksson BI, Borris LC, Friedmann RJ, Haas S, Huisman MV, Kakkar AK, Bandel TJ, Beckmann H, Mühlhofer E, Misselwitz F, Geerts W, RECORD1 Study Group (2008) Rivaroxaban versus exoxaparin for thromboprophylaxis after hip arthroplasty. N Engl J Med 358:2675–2775
Hippisley-Cox J, Coupland C (2010) Individualising the risks of statins in men and women in England and Wales: population-based cohort study. Heart 96:939–947
Hirsch J, O’Donnell M, Weitz JI (2005) New anticoagulants. Blood 105:453–463
Hudson TL, Dukes SF, Reilly K (2006) Use of local anesthesia for arterial punctures. Am J Crit Care 15:595–599
Krentz AJ, Bailey CJ (2005) Oral antidiabetic agents: current role in type 2 diabetes mellitus. Drugs 65:385–411
Lemon SJ Jr, Crannage AJ (2011) Pharmacologic anticoagulation reversal in the emergency department. Adv Emerg Nurs J 33:212–223
Mager A, Strasberg B, Rechavia E, Birnbaum Y, Mazur A, Yativ N, Sclarovsky S (1994) Clinical significance and predisposing factors to symptomatic bradycardia and hypotension after percutaneous transluminal coronary angioplasty. Am J Cardiol 74:1085–1088
Mayfield JA, White RD (2004) Insulin therapy for type 2 diabetes: rescue, augmentation, and replacement of beta-cell function. Am Fam Physician 70:489–500
NICE (2011) Hypertension: clinical management of primary hypertension in adults (NICE clinical guideline 127). National Institute for Health and Clinical Excellence, London
Olkolla KT, Ahonen J (2008) Midazolam and other benzodiazepines. Handb Exp Pharmacol 182:335–360
Rao SV, Ohman EM (2010) Anticoagulant therapy for percutaneous coronary intervention. Circ Cardiovasc Interv 3:80–88
Royal College of Physicians (2011) Type 2 diabetes: national clinical guideline for management in primary and secondary care (update). Royal College of Physicians, London
Royal College of Radiologists (2010) Standards for intravascular contrast agent administration to adult patients, 2nd edn. Royal College of Radiologists, London
Sangkuhl K, Klein TE, Altman RB (2010) Clopidogrel pathway. Pharmacogenet Genomics 20:463–465
Schlicker E, Kathmann M (2008) Presynaptic neuropeptide receptors. Handb Exp Pharmacol 184:409–434
Shearer MJ, Newman P (2008) Metabolism and cell biology of vitamin K. Thromb Hemost 100:530–547
Smith SW (2010) Drugs and pharmaceuticals: management of intoxication and antidotes. EXS 100:397–460
Thomsen HS, Morcos SK (2003) Contrast media and the kidney: European Society of Urogenital Radiology (ESUR) guidelines. Br J Radiol 76:513–518
Vitrat N, Letestu R, Massé R, Lazar V, Vainchenker W, Debili N (2000) Thromboxane synthase has the same pattern of expression as platelet specific glycoproteins during human megakaryocyte differentiation. Thromb Hemost 83:759–768
Weirich J, Antoni H (1998) Rate-dependence of antiarrhythmic and proarrhythmic properties of class I and class III antiarrhythmic drugs. Basic Res Cardiol 93(Suppl 1):125–132
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Dent, G., Cowling, M.G. (2012). Drugs Used in Vascular Interventional Radiology. In: Cowling, M. (eds) Vascular Interventional Radiology. Medical Radiology(). Springer, Berlin, Heidelberg. https://doi.org/10.1007/174_2012_610
Download citation
DOI: https://doi.org/10.1007/174_2012_610
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-27877-8
Online ISBN: 978-3-642-27878-5
eBook Packages: MedicineMedicine (R0)